A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of DDP733 for IBS-c

Clinical trial NCT00215566 · COMPLETED

Trial details

NCT number: NCT00215566
Sponsor: Dynogen Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Irritable Bowel Syndrome With Constipation Irritable Bowel Syndrome

Start date: 2005-09-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.